newsfilter
← Latest News
GlobeNewswire·

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and healthcare services company focused on sleep related breathing